世界の出血性脳卒中治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hemorrhagic Stroke Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4299
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、123ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、出血性脳卒中治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（降圧剤、抗凝固剤、抗てんかん剤、その他）、用途別市場規模（病院、クリニック、外科医院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・出血性脳卒中治療の市場動向
・企業の競争状況、市場シェア
・出血性脳卒中治療の種類別市場規模と予測2016-2027（降圧剤、抗凝固剤、抗てんかん剤、その他）
・出血性脳卒中治療の用途別市場規模と予測2016-2027（病院、クリニック、外科医院、その他）
・出血性脳卒中治療の北米市場規模2016-2027（アメリカ、カナダ）
・出血性脳卒中治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・出血性脳卒中治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・出血性脳卒中治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・出血性脳卒中治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Roche、Boehringer Ingelheim、Bristol-Myers Squibb、Johnson & Johnson、Daiichi Sankyo Co. Ltd.、AstraZeneca、Biogen、SanBio Co, Ltd、Athersys, Inc.、Abbott、Merck、Pfizer、Novartis AG、Sanofi S.A.、Medtronic）
・結論

Market Analysis and Insights: Global Hemorrhagic Stroke Treatment Market
The global Hemorrhagic Stroke Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemorrhagic Stroke Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemorrhagic Stroke Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemorrhagic Stroke Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemorrhagic Stroke Treatment market.

Global Hemorrhagic Stroke Treatment Scope and Market Size
Hemorrhagic Stroke Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemorrhagic Stroke Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antihypertensives
Anticoagulants
Anticonvulsants
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Boehringer Ingelheim
Bristol-Myers Squibb
Johnson & Johnson
Daiichi Sankyo Co. Ltd.
AstraZeneca
Biogen
SanBio Co, Ltd
Athersys, Inc.
Abbott
Merck
Pfizer
Novartis AG
Sanofi S.A.
Medtronic

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemorrhagic Stroke Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antihypertensives
1.2.3 Anticoagulants
1.2.4 Anticonvulsants
1.2.5 Others
1.3 Market by Application
1.3.1 Global Hemorrhagic Stroke Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hemorrhagic Stroke Treatment Market Perspective (2016-2027)
2.2 Hemorrhagic Stroke Treatment Growth Trends by Regions
2.2.1 Hemorrhagic Stroke Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hemorrhagic Stroke Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hemorrhagic Stroke Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hemorrhagic Stroke Treatment Industry Dynamic
2.3.1 Hemorrhagic Stroke Treatment Market Trends
2.3.2 Hemorrhagic Stroke Treatment Market Drivers
2.3.3 Hemorrhagic Stroke Treatment Market Challenges
2.3.4 Hemorrhagic Stroke Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hemorrhagic Stroke Treatment Players by Revenue
3.1.1 Global Top Hemorrhagic Stroke Treatment Players by Revenue (2016-2021)
3.1.2 Global Hemorrhagic Stroke Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hemorrhagic Stroke Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hemorrhagic Stroke Treatment Revenue
3.4 Global Hemorrhagic Stroke Treatment Market Concentration Ratio
3.4.1 Global Hemorrhagic Stroke Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemorrhagic Stroke Treatment Revenue in 2020
3.5 Hemorrhagic Stroke Treatment Key Players Head office and Area Served
3.6 Key Players Hemorrhagic Stroke Treatment Product Solution and Service
3.7 Date of Enter into Hemorrhagic Stroke Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hemorrhagic Stroke Treatment Breakdown Data by Type
4.1 Global Hemorrhagic Stroke Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hemorrhagic Stroke Treatment Forecasted Market Size by Type (2022-2027)

5 Hemorrhagic Stroke Treatment Breakdown Data by Application
5.1 Global Hemorrhagic Stroke Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hemorrhagic Stroke Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hemorrhagic Stroke Treatment Market Size (2016-2027)
6.2 North America Hemorrhagic Stroke Treatment Market Size by Type
6.2.1 North America Hemorrhagic Stroke Treatment Market Size by Type (2016-2021)
6.2.2 North America Hemorrhagic Stroke Treatment Market Size by Type (2022-2027)
6.2.3 North America Hemorrhagic Stroke Treatment Market Size by Type (2016-2027)
6.3 North America Hemorrhagic Stroke Treatment Market Size by Application
6.3.1 North America Hemorrhagic Stroke Treatment Market Size by Application (2016-2021)
6.3.2 North America Hemorrhagic Stroke Treatment Market Size by Application (2022-2027)
6.3.3 North America Hemorrhagic Stroke Treatment Market Size by Application (2016-2027)
6.4 North America Hemorrhagic Stroke Treatment Market Size by Country
6.4.1 North America Hemorrhagic Stroke Treatment Market Size by Country (2016-2021)
6.4.2 North America Hemorrhagic Stroke Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hemorrhagic Stroke Treatment Market Size (2016-2027)
7.2 Europe Hemorrhagic Stroke Treatment Market Size by Type
7.2.1 Europe Hemorrhagic Stroke Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hemorrhagic Stroke Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hemorrhagic Stroke Treatment Market Size by Type (2016-2027)
7.3 Europe Hemorrhagic Stroke Treatment Market Size by Application
7.3.1 Europe Hemorrhagic Stroke Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hemorrhagic Stroke Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hemorrhagic Stroke Treatment Market Size by Application (2016-2027)
7.4 Europe Hemorrhagic Stroke Treatment Market Size by Country
7.4.1 Europe Hemorrhagic Stroke Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hemorrhagic Stroke Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hemorrhagic Stroke Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Type
8.2.1 Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Application
8.3.1 Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Region
8.4.1 Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hemorrhagic Stroke Treatment Market Size (2016-2027)
9.2 Latin America Hemorrhagic Stroke Treatment Market Size by Type
9.2.1 Latin America Hemorrhagic Stroke Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hemorrhagic Stroke Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hemorrhagic Stroke Treatment Market Size by Type (2016-2027)
9.3 Latin America Hemorrhagic Stroke Treatment Market Size by Application
9.3.1 Latin America Hemorrhagic Stroke Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hemorrhagic Stroke Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hemorrhagic Stroke Treatment Market Size by Application (2016-2027)
9.4 Latin America Hemorrhagic Stroke Treatment Market Size by Country
9.4.1 Latin America Hemorrhagic Stroke Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hemorrhagic Stroke Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hemorrhagic Stroke Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Type
10.2.1 Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Application
10.3.1 Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Country
10.4.1 Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Hemorrhagic Stroke Treatment Introduction
11.1.4 Roche Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Hemorrhagic Stroke Treatment Introduction
11.2.4 Boehringer Ingelheim Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Hemorrhagic Stroke Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Hemorrhagic Stroke Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Daiichi Sankyo Co. Ltd.
11.5.1 Daiichi Sankyo Co. Ltd. Company Details
11.5.2 Daiichi Sankyo Co. Ltd. Business Overview
11.5.3 Daiichi Sankyo Co. Ltd. Hemorrhagic Stroke Treatment Introduction
11.5.4 Daiichi Sankyo Co. Ltd. Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.5.5 Daiichi Sankyo Co. Ltd. Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Hemorrhagic Stroke Treatment Introduction
11.6.4 AstraZeneca Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Biogen
11.7.1 Biogen Company Details
11.7.2 Biogen Business Overview
11.7.3 Biogen Hemorrhagic Stroke Treatment Introduction
11.7.4 Biogen Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.7.5 Biogen Recent Development
11.8 SanBio Co, Ltd
11.8.1 SanBio Co, Ltd Company Details
11.8.2 SanBio Co, Ltd Business Overview
11.8.3 SanBio Co, Ltd Hemorrhagic Stroke Treatment Introduction
11.8.4 SanBio Co, Ltd Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.8.5 SanBio Co, Ltd Recent Development
11.9 Athersys, Inc.
11.9.1 Athersys, Inc. Company Details
11.9.2 Athersys, Inc. Business Overview
11.9.3 Athersys, Inc. Hemorrhagic Stroke Treatment Introduction
11.9.4 Athersys, Inc. Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.9.5 Athersys, Inc. Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Hemorrhagic Stroke Treatment Introduction
11.10.4 Abbott Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.10.5 Abbott Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Hemorrhagic Stroke Treatment Introduction
11.11.4 Merck Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.11.5 Merck Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Hemorrhagic Stroke Treatment Introduction
11.12.4 Pfizer Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.12.5 Pfizer Recent Development
11.13 Novartis AG
11.13.1 Novartis AG Company Details
11.13.2 Novartis AG Business Overview
11.13.3 Novartis AG Hemorrhagic Stroke Treatment Introduction
11.13.4 Novartis AG Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.13.5 Novartis AG Recent Development
11.14 Sanofi S.A.
11.14.1 Sanofi S.A. Company Details
11.14.2 Sanofi S.A. Business Overview
11.14.3 Sanofi S.A. Hemorrhagic Stroke Treatment Introduction
11.14.4 Sanofi S.A. Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.14.5 Sanofi S.A. Recent Development
11.15 Medtronic
11.15.1 Medtronic Company Details
11.15.2 Medtronic Business Overview
11.15.3 Medtronic Hemorrhagic Stroke Treatment Introduction
11.15.4 Medtronic Revenue in Hemorrhagic Stroke Treatment Business (2016-2021)
11.15.5 Medtronic Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hemorrhagic Stroke Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antihypertensives
Table 3. Key Players of Anticoagulants
Table 4. Key Players of Anticonvulsants
Table 5. Key Players of Others
Table 6. Global Hemorrhagic Stroke Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hemorrhagic Stroke Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hemorrhagic Stroke Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Hemorrhagic Stroke Treatment Market Share by Regions (2016-2021)
Table 10. Global Hemorrhagic Stroke Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Hemorrhagic Stroke Treatment Market Share by Regions (2022-2027)
Table 12. Hemorrhagic Stroke Treatment Market Trends
Table 13. Hemorrhagic Stroke Treatment Market Drivers
Table 14. Hemorrhagic Stroke Treatment Market Challenges
Table 15. Hemorrhagic Stroke Treatment Market Restraints
Table 16. Global Hemorrhagic Stroke Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Hemorrhagic Stroke Treatment Market Share by Players (2016-2021)
Table 18. Global Top Hemorrhagic Stroke Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemorrhagic Stroke Treatment as of 2020)
Table 19. Ranking of Global Top Hemorrhagic Stroke Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Hemorrhagic Stroke Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hemorrhagic Stroke Treatment Product Solution and Service
Table 23. Date of Enter into Hemorrhagic Stroke Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hemorrhagic Stroke Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Hemorrhagic Stroke Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Hemorrhagic Stroke Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Hemorrhagic Stroke Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Hemorrhagic Stroke Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Hemorrhagic Stroke Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Hemorrhagic Stroke Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Hemorrhagic Stroke Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Hemorrhagic Stroke Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Hemorrhagic Stroke Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Hemorrhagic Stroke Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Hemorrhagic Stroke Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Hemorrhagic Stroke Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Hemorrhagic Stroke Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Hemorrhagic Stroke Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Hemorrhagic Stroke Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Hemorrhagic Stroke Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Hemorrhagic Stroke Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Hemorrhagic Stroke Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Hemorrhagic Stroke Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Hemorrhagic Stroke Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Hemorrhagic Stroke Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Hemorrhagic Stroke Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Hemorrhagic Stroke Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Hemorrhagic Stroke Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Hemorrhagic Stroke Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Hemorrhagic Stroke Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Hemorrhagic Stroke Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Hemorrhagic Stroke Treatment Product
Table 66. Roche Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Boehringer Ingelheim Company Details
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Hemorrhagic Stroke Treatment Product
Table 71. Boehringer Ingelheim Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Development
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Hemorrhagic Stroke Treatment Product
Table 76. Bristol-Myers Squibb Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Hemorrhagic Stroke Treatment Product
Table 81. Johnson & Johnson Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 82. Johnson & Johnson Recent Development
Table 83. Daiichi Sankyo Co. Ltd. Company Details
Table 84. Daiichi Sankyo Co. Ltd. Business Overview
Table 85. Daiichi Sankyo Co. Ltd. Hemorrhagic Stroke Treatment Product
Table 86. Daiichi Sankyo Co. Ltd. Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 87. Daiichi Sankyo Co. Ltd. Recent Development
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Hemorrhagic Stroke Treatment Product
Table 91. AstraZeneca Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 92. AstraZeneca Recent Development
Table 93. Biogen Company Details
Table 94. Biogen Business Overview
Table 95. Biogen Hemorrhagic Stroke Treatment Product
Table 96. Biogen Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 97. Biogen Recent Development
Table 98. SanBio Co, Ltd Company Details
Table 99. SanBio Co, Ltd Business Overview
Table 100. SanBio Co, Ltd Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 101. SanBio Co, Ltd Recent Development
Table 102. Athersys, Inc. Company Details
Table 103. Athersys, Inc. Business Overview
Table 104. Athersys, Inc. Hemorrhagic Stroke Treatment Product
Table 105. Athersys, Inc. Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 106. Athersys, Inc. Recent Development
Table 107. Abbott Company Details
Table 108. Abbott Business Overview
Table 109. Abbott Hemorrhagic Stroke Treatment Product
Table 110. Abbott Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 111. Abbott Recent Development
Table 112. Merck Company Details
Table 113. Merck Business Overview
Table 114. Merck Hemorrhagic Stroke Treatment Product
Table 115. Merck Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 116. Merck Recent Development
Table 117. Pfizer Company Details
Table 118. Pfizer Business Overview
Table 119. Pfizer Hemorrhagic Stroke Treatment Product
Table 120. Pfizer Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 121. Pfizer Recent Development
Table 122. Novartis AG Company Details
Table 123. Novartis AG Business Overview
Table 124. Novartis AG Hemorrhagic Stroke Treatment Product
Table 125. Novartis AG Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 126. Novartis AG Recent Development
Table 127. Sanofi S.A. Company Details
Table 128. Sanofi S.A. Business Overview
Table 129. Sanofi S.A. Hemorrhagic Stroke Treatment Product
Table 130. Sanofi S.A. Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 131. Sanofi S.A. Recent Development
Table 132. Medtronic Company Details
Table 133. Medtronic Business Overview
Table 134. Medtronic Hemorrhagic Stroke Treatment Product
Table 135. Medtronic Revenue in Hemorrhagic Stroke Treatment Business (2016-2021) & (US$ Million)
Table 136. Medtronic Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemorrhagic Stroke Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antihypertensives Features
Figure 3. Anticoagulants Features
Figure 4. Anticonvulsants Features
Figure 5. Others Features
Figure 6. Global Hemorrhagic Stroke Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Hemorrhagic Stroke Treatment Report Years Considered
Figure 12. Global Hemorrhagic Stroke Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Hemorrhagic Stroke Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Hemorrhagic Stroke Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Hemorrhagic Stroke Treatment Market Share by Regions (2022-2027)
Figure 16. Global Hemorrhagic Stroke Treatment Market Share by Players in 2020
Figure 17. Global Top Hemorrhagic Stroke Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemorrhagic Stroke Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Hemorrhagic Stroke Treatment Revenue in 2020
Figure 19. Global Hemorrhagic Stroke Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Hemorrhagic Stroke Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Hemorrhagic Stroke Treatment Market Share by Type (2016-2027)
Figure 23. North America Hemorrhagic Stroke Treatment Market Share by Application (2016-2027)
Figure 24. North America Hemorrhagic Stroke Treatment Market Share by Country (2016-2027)
Figure 25. United States Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hemorrhagic Stroke Treatment Market Share by Type (2016-2027)
Figure 29. Europe Hemorrhagic Stroke Treatment Market Share by Application (2016-2027)
Figure 30. Europe Hemorrhagic Stroke Treatment Market Share by Country (2016-2027)
Figure 31. Germany Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hemorrhagic Stroke Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Hemorrhagic Stroke Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Hemorrhagic Stroke Treatment Market Share by Region (2016-2027)
Figure 41. China Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hemorrhagic Stroke Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Hemorrhagic Stroke Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Hemorrhagic Stroke Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hemorrhagic Stroke Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Hemorrhagic Stroke Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Hemorrhagic Stroke Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Hemorrhagic Stroke Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 64. Daiichi Sankyo Co. Ltd. Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 66. Biogen Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 67. SanBio Co, Ltd Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 68. Athersys, Inc. Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 69. Abbott Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 70. Merck Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 72. Novartis AG Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 73. Sanofi S.A. Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 74. Medtronic Revenue Growth Rate in Hemorrhagic Stroke Treatment Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

以下、関連資料のご紹介

世界の脳卒中治療市場規模・現状・予測（2021年-2027年）

Global Stroke Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4910 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、脳卒中治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（虚血性脳卒中、出血性脳卒中）、用途別市場規模（病院薬局、小売薬局、オンライン販売）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の急性虚血性脳卒中用医薬品市場規模・現状・予測（2021年-2027年）

Global Acute Ischemic Stroke Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5565 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、急性虚血性脳卒中用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（タブレット、カプセル、その他）、用途別市場規模（病院、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

出血性ショック治療のグローバル市場調査 2019年

QYR9NV05966 2019年11月12日 107Pages
※本調査レポートは、出血性ショック治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、YW-356、NVX-408、ニュートロライド、LB-1148、その他に...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の脳卒中治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Stroke Treatment Market The global Stroke Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
出血性ショック治療のグローバル市場調査 2019年 The global Hemorrhagic Shock Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hemorrhagic Shock Treatment volume and value at global level, regional level and company level. From a global p…
サークル急性虚血性脳卒中のグローバル市場2021 Market Analysis and Insights: Global Circle Acute Ischemic Stroke Market The global Circle Acute Ischemic Stroke market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Circle Acute Ischemic Stroke Scope and Market Size …
世界の急性虚血性脳卒中用医薬品市場規模・現状・予測（2021年-2027年） Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important ce…
世界の痔瘻非外科治療市場規模・現状・予測（2021年-2027年） Anal fistula treatment involves use of both surgical and non-surgical approaches for effective removal of anal fistulae in patients. Non-surgical methods include drugs as well as fibrin glue injections, adipose stem cell therapy, and collagen paste. Market Analysis and Insights: Global Anal Fistula …